Cargando…

Sprouty2 loss‐induced IL6 drives castration‐resistant prostate cancer through scavenger receptor B1

Metastatic castration‐resistant prostate cancer (mCRPC) is a lethal form of treatment‐resistant prostate cancer and poses significant therapeutic challenges. Deregulated receptor tyrosine kinase (RTK) signalling mediated by loss of tumour suppressor Sprouty2 (SPRY2) is associated with treatment resi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Rachana, Fleming, Janis, Mui, Ernest, Loveridge, Carolyn, Repiscak, Peter, Blomme, Arnaud, Harle, Victoria, Salji, Mark, Ahmad, Imran, Teo, Katy, Hamdy, Freddie C, Hedley, Ann, van den Broek, Niels, Mackay, Gillian, Edwards, Joanne, Sansom, Owen J, Leung, Hing Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887544/ https://www.ncbi.nlm.nih.gov/pubmed/29540470 http://dx.doi.org/10.15252/emmm.201708347

Ejemplares similares

Multi-omics & pathway analysis identify potential roles for tumor N-acetyl aspartate accumulation in murine models of castration-resistant prostate cancer
por: Salji, Mark J., et al.
Publicado: (2022)

Phase II proof‐of‐concept study of atorvastatin in castration‐resistant prostate cancer
por: Rushworth, Linda K., et al.
Publicado: (2022)

18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy
por: Malviya, Gaurav, et al.
Publicado: (2020)

Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration
por: Loveridge, Carolyn J., et al.
Publicado: (2019)

BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration
por: Loveridge, Carolyn J., et al.
Publicado: (2019)

Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression
por: Patel, Rachana, et al.
Publicado: (2022)

Inducing Sprouty degradation
por: LeBrasseur, Nicole
Publicado: (2003)

In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer
por: Rushworth, Linda K, et al.
Publicado: (2020)

Sprouty3, but Not Sprouty1, Expression Is Beneficial for the Malignant Potential of Osteosarcoma Cells
por: Kamptner, Anna Zita Mehira, et al.
Publicado: (2021)

2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer
por: Blomme, Arnaud, et al.
Publicado: (2020)

Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial–mesenchymal transition
por: Zhang, Q, et al.
Publicado: (2016)

Peri-prostatic Fat Volume Measurement as a Predictive Tool for Castration Resistance in Advanced Prostate Cancer
por: Salji, Mark, et al.
Publicado: (2018)

The developing story of Sprouty and cancer
por: Masoumi-Moghaddam, Samar, et al.
Publicado: (2014)

Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein
por: Gao, Xianlong, et al.
Publicado: (2017)

Erratum: Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial–mesenchymal transition
por: Zhang, Q, et al.
Publicado: (2017)

Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity
por: Loveridge, Carolyn J., et al.
Publicado: (2017)

PPAR-gamma induced AKT3 expression increases levels of mitochondrial biogenesis driving prostate cancer
por: Galbraith, Laura C. A., et al.
Publicado: (2021)

Cosuppression of Sprouty and Sprouty-Related Negative Regulators of FGF Signalling in Prostate Cancer: A Working Hypothesis
por: Assinder, Stephen J., et al.
Publicado: (2015)

Expression and Functional Role of Sprouty-2 in Breast Morphogenesis
por: Sigurdsson, Valgardur, et al.
Publicado: (2013)

Sprouty2 enhances the tumorigenic potential of glioblastoma cells
por: Park, Jong-Whi, et al.
Publicado: (2018)

The Sprouty/Spred family as tumor suppressors: Coming of age
por: Kawazoe, Tetsuro, et al.
Publicado: (2019)

Subcellular Localization of Sprouty2 in Human Glioma Cells
por: Hausott, Barbara, et al.
Publicado: (2019)

Sprouty 1 is associated with stemness and cancer progression in glioblastoma
por: Park, Seo-Young, et al.
Publicado: (2022)

Sprouty4 is epigenetically upregulated in human colorectal cancer
por: Stuckel, Alexei J., et al.
Publicado: (2022)

Sprouty-2 Controls c-Met Expression and Metastatic Potential of Colon Cancer Cells: Sprouty/c-Met Upregulation in Human Colonic Adenocarcinomas
por: Holgren, Cory, et al.
Publicado: (2010)

Aberrant expression of hSef and Sprouty4 in endometrial adenocarcinoma
por: ZHANG, HUI, et al.
Publicado: (2016)

Sprouty2 mediated tuning of signalling is essential for somite myogenesis
por: Abu-Elmagd, Muhammad, et al.
Publicado: (2015)

Sprouty2—a Novel Therapeutic Target in the Nervous System?
por: Hausott, Barbara, et al.
Publicado: (2018)

SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis
por: Gao, Meiling, et al.
Publicado: (2012)

Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells
por: Celik-Selvi, Burcu Emine, et al.
Publicado: (2019)

Sprouty genes are essential for the normal development of epibranchial ganglia in the mouse embryo
por: Simrick, Subreena, et al.
Publicado: (2011)

Sprouty genes regulate proliferation and survival of human embryonic stem cells
por: Felfly, Hady, et al.
Publicado: (2013)

Regulation of CD4(+) and CD8(+) Effector Responses by Sprouty-1
por: Collins, Sam, et al.
Publicado: (2012)

Hyperplasia of Interstitial Cells of Cajal in Sprouty Homolog 4 Deficient Mice
por: Thys, An, et al.
Publicado: (2015)

Sprouty2 in the Dorsal Hippocampus Regulates Neurogenesis and Stress Responsiveness in Rats
por: Dow, Antonia L., et al.
Publicado: (2015)

Overexpression of sprouty 1 protein in human oral squamous cell carcinogenesis
por: Wang, Yen-Yun, et al.
Publicado: (2021)

Sprouty4 at the crossroads of Trk neurotrophin receptor signaling suppression by glucocorticoids
por: Ferrero Restelli, Facundo, et al.
Publicado: (2023)

THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer
por: Blomme, Arnaud, et al.
Publicado: (2022)

Sprouty Proteins Inhibit Receptor-mediated Activation of Phosphatidylinositol-specific Phospholipase C
por: Akbulut, Simge, et al.
Publicado: (2010)

Sprouty1 is a candidate tumor suppressor gene in medullary thyroid carcinoma
por: Macià, Anna, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vcfkf2gtkpvgnari8tqadkfl0c